Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting deprescribing trials.|
|Full bibliographic reference||Blom JW, Muth C, Glasziou P, McCormack JP, Perera R, Poortvliet RKE, Numans ME, Thürmann P, Thiem U, Thio SL, Van Driel M, Beyer M, Van den Akker M, Knottnerus JA. Describing deprescribing trials better: an elaboration of the CONSORT statement. J Clin Epidemiol. 2020;127:87-95.|
|Study design||Clinical trials, Experimental studies|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.)|
|Record last updated on||June 18, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.